What is IBD (Inflammatory Bowel Disease): Symptoms, IBD vs IBS, Treatment and Diet

Your gut is supposed to be the quiet colleague who does the work and never complains. When it starts sending urgent messages many times a day, with blood, weight loss or night-time trips to the toilet, it is not being dramatic. It may be inflammatory bowel disease, or IBD.

IBD is one of the most searched gut conditions in the world and one of the most misunderstood. Below, I explain what IBD is, what IBD symptoms look like, how IBD differs from IBS, how it is treated and where food genuinely helps. Everything here is meant to sit alongside your gastroenterologist’s care, never replace it.

What Is IBD?

IBD stands for inflammatory bowel disease. It is a long-term condition in which the immune system keeps the digestive tract inflamed, with flare-ups and quieter periods called remission [3]. The two main types are Crohn’s disease [1] and ulcerative colitis [2].

Think of inflammation as a fire alarm. In a healthy gut it rings when there is real danger, then switches off. In IBD the alarm keeps ringing without a fire, and over time the building (your gut lining) gets damaged.

Feature	Crohn’s disease	Ulcerative colitis
Where it happens	Anywhere from mouth to anus, often the end of the small intestine and colon	Colon and rectum only
Pattern	Patchy, healthy areas between inflamed ones	Continuous, starting at the rectum
Depth	Can involve the full thickness of the bowel wall	Surface lining
Typical signs	Pain, diarrhoea, weight loss, strictures, fistulas	Bloody diarrhoea, urgency, cramps

Many people search “Crohn’s disease IBD” wondering if they are different illnesses. They are not: Crohn’s disease is one form of IBD.

Is IBD Common in India? Why the Numbers Are Rising

IBD was once called a “Western disease”. That label is outdated. A large review found that IBD is now global, with incidence accelerating in newly industrialised countries as societies become more westernised [4], building on earlier evidence of rising incidence and prevalence over time [5]. In the West, new cases have levelled off, but prevalence keeps climbing because people live with IBD for decades [6]. Asia is following the same road.

In India, estimates differ but the direction is clear. One analysis put the burden at about 1.4 million people in 2010, the highest in Asia [8]. A newer Global Burden of Disease analysis found the global burden lower than earlier estimates, yet the number of people with IBD in India roughly doubled between 1990 and 2019, from about 0.13 to 0.27 million [9]. Indian experts expect one of the largest IBD burdens in the world over time [7], with real challenges in diagnosis and access to care [10].

The takeaway: if you live in India and your gut symptoms were brushed off, IBD is not “too rare” to consider.

What Causes IBD? IBD and Inflammation Explained

There is no single cause. IBD seems to arise when genes, the immune system, gut bacteria and the environment interact [11] [12]. People with IBD tend to have a less diverse gut microbiome than healthy people [13]. To see how gut inflammation shows up in the body, read my guide to gut inflammation and the brain fog connection and the gut barrier problem called leaky gut.

Known risk factors include:

• Smoking, which raises the risk of Crohn’s disease [14] (smoking is never a treatment, whatever it does to colitis risk).

• Antibiotics, linked with new-onset Crohn’s disease but not ulcerative colitis [15].

• Regular aspirin or NSAID use, associated with higher risk in a large cohort [16].

• A highly processed diet (covered below).

• Family history, although most people with IBD have no affected relative.

These are risk factors, not blame. Nobody develops IBD from one bad meal.

IBD Symptoms: Signs You Should Not Ignore

IBD symptoms vary with the type and the part of the gut involved [1] [2]:

• Diarrhoea lasting more than a few weeks

• Blood or mucus in the stool

• Cramping abdominal pain and urgent bowel movements

• Waking at night to pass stool

• Unplanned weight loss and poor appetite

• Fatigue and anaemia

• Fever during flares

• Pain, swelling or fistulas around the anus (more typical of Crohn’s)

• Outside the gut: joint pain, mouth ulcers, skin rashes and red, painful eyes

Clinical insight: Symptoms alone cannot separate IBD from a functional gut problem. Blood in the stool, night symptoms, weight loss and anaemia are red flags that call for tests, not another round of diet experiments.

If you recognise several of these, speak to a gastroenterologist soon. For milder, long-running symptoms, my posts on ten signs of an unhealthy gut and bloating can help you decide what to track.

IBD vs IBS: How to Tell the Difference

This is the most common confusion, and the reason “IBS vs IBD” is searched so often. IBS is a disorder of gut function and sensitivity, with no visible inflammation or ulcers. IBD is a disease with measurable inflammation and tissue damage.

	IBD	IBS
Visible inflammation or ulcers	Yes	No
Blood in stool	Common	Not typical
Weight loss, anaemia	Possible	Not typical
Stool calprotectin	Often raised	Usually normal
Needs colonoscopy and biopsy	Yes, to confirm	Often only if red flags
Main treatment	Anti-inflammatory medicines, sometimes surgery	Diet, gut-directed therapy, symptom treatment

A simple stool test for calprotectin, a marker of gut inflammation, is very good at flagging who needs a colonoscopy [17] and at helping rule out IBD in people with IBS-type symptoms [18].

The two can also overlap. Roughly one in three people with IBD in remission still has IBS-type symptoms [19]. In India there is a third look-alike: intestinal tuberculosis can mimic Crohn’s disease, and telling them apart matters because the treatments are very different [20].

For the IBS side of the story, see stomach pain after every meal, why IBS symptoms return after normal reports and why IBS in Indian women is often misdiagnosed.

How Is IBD Diagnosed?

Diagnosis combines blood tests (anaemia, CRP), stool calprotectin, colonoscopy with biopsies and, for the small bowel, imaging such as MR enterography [21]. Stool microbiome panels such as the GI-MAP can add useful context for gut health work, but they do not replace colonoscopy for diagnosing IBD.

IBD Treatment: What Doctors Do

IBD treatment aims to calm inflammation, heal the gut lining and keep you in remission. Depending on the type and severity, this can include aminosalicylates (mainly for colitis), short courses of steroids, immunomodulators, biologics and small-molecule drugs, and sometimes surgery [22] [23]. Modern care follows a “treat-to-target” approach: symptom relief, normal inflammatory markers and healing of the gut lining on endoscopy [24]. Regular check-ups also matter, because long-standing colitis needs colonoscopy surveillance, although colorectal cancer risk in IBD has been falling over time [25].

Where does a nutritionist fit? Alongside medicine, not instead of it. I explain the split in gut health nutritionist vs gastroenterologist.

Diet for IBD: What the Evidence Actually Says

Here is the honest truth: there is no single “IBD diet”. Diet influences risk and symptoms, but it is rarely a stand-alone treatment [26]. What the evidence supports so far:

• Eat mostly minimally processed food. International IBD experts advise limiting ultra-processed foods and certain additives, and favouring fruit, vegetables and home-cooked meals [27]. In a large cohort, people eating five or more servings of ultra-processed food a day had about an 80% higher risk of developing IBD [28]. Emulsifiers promoted colitis in mice, though human proof is still limited [29].

  
  

• Fibre and plants help prevention. Higher long-term fibre intake, especially from fruit, was linked with a lower Crohn’s risk [30], and a Mediterranean-style pattern with lower later-onset Crohn’s [31].

  
  

• Structured diets exist, with limits. In children with mild to moderate Crohn’s, the Crohn’s Disease Exclusion Diet with partial enteral nutrition was better tolerated and kept more children in remission at week 12 than exclusive enteral nutrition [32]. Exclusive enteral nutrition has its strongest evidence in children, and the evidence in adults is less certain [33].

  
  

• Stricter is not always better. In adults with Crohn’s, the Specific Carbohydrate Diet performed no better than a Mediterranean-style diet for symptom remission [34], and popular “anti-inflammatory IBD diets” rest on very small studies such as one case series [35]. My general guide to anti-inflammatory foods is a good everyday framework, but it is not an IBD treatment.

  
  

• Low FODMAP can ease symptoms, not inflammation. In people with quiet IBD and IBS-type symptoms, a low FODMAP diet reduced symptoms without changing inflammatory markers [36]. It is best done short-term and guided by a professional.

	During a flare	During remission
Goal	Calm symptoms, protect nutrition	Widen variety, rebuild gut resilience
Typical approach	Smaller, frequent, softer meals such as khichdi, well-cooked dal, idli, rice, banana, boiled vegetables; follow your doctor’s advice on fibre if you have narrowing	Gradually return to fruit, vegetables, pulses and whole grains as tolerated
Watch for	Dehydration, weight loss, skipped meals	Over-restriction and food fear

Clinical insight: The biggest dietary risk in IBD is often not one “trigger” food but long lists of avoided foods that quietly cause malnutrition. Elimination should always have an end date and a plan to reintroduce foods.

Fermented Indian staples can fit, depending on your tolerance. Read curd vs probiotic yogurt, buttermilk and my top 10 foods for gut health.

Nutrient Gaps in IBD: Iron, B12 and More

Guidelines recommend screening everyone with IBD for malnutrition and deficiencies [37]. Iron deficiency anaemia is especially common [38] and needs proper testing and treatment, sometimes with intravenous iron [39].

Vitamin B12 deficiency is a particular risk with ileal Crohn’s disease or bowel resection [40]. Food can support recovery; see iron-rich Indian foods and zinc-rich foods, but do not self-supplement without testing.

Probiotics, FMT and Curcumin: Hype or Help?

Gut bacteria make short-chain fatty acids such as butyrate that help regulate the gut lining and immune response [41], which is why microbiome-based ideas are popular. A multi-strain probiotic helped induce remission in mild to moderate ulcerative colitis in an Indian trial [42].

Intensive faecal microbiota transplantation worked better than placebo in active ulcerative colitis, but it remains a specialist, trial-based treatment [43]. Curcumin added to standard medicine helped maintain remission in one small Japanese trial [44]. These are add-ons, not replacements. To choose a supplement safely, start with how to choose the best probiotics and prebiotics and probiotics.

Stress, Sleep and the Gut-Brain Axis

Stress does not cause IBD, but the gut and brain talk constantly, and that conversation can shape symptoms [45]. Psychological therapies may improve distress and quality of life, although evidence that they change inflammation itself is limited [46]. Explore the gut-brain connection and the vagus nerve.

IBD in Teens and Young Athletes

IBD often begins in the teens and twenties, when growth, school, sport and exams all compete for energy. Regular physical activity was linked with a lower risk of Crohn’s disease [47], and exercise was associated with fewer flares in people in remission [48].

In children, guidelines stress monitoring growth and using nutrition therapy as part of Crohn’s treatment [49] and in colitis care [50]. Young athletes need enough fuel and protein to train and heal, which is where individual sports nutrition and child and teen nutrition planning matters.

How a Gut Health Nutritionist Supports IBD Care

I work alongside your gastroenterologist. My role is to review your diet quality and nutrient gaps, build a plan around Indian food habits, guide safe reintroduction after restriction, check supplements for safety and help you eat well in both flare and remission. If you want support, explore my gut health nutrition service or contact me.

IBD FAQs

1. Is IBD the same as IBS?

No. IBD involves visible, measurable inflammation of the gut. IBS is a functional disorder without that damage, though the two can overlap [19].

2. Can IBD be cured?

There is no medical cure for Crohn’s disease, but many people reach long remission. Ulcerative colitis can be cured by removing the colon, which is a major decision made with your surgeon [22] [23].

3. Is IBD an autoimmune disease?

IBD is an immune-mediated inflammatory condition. Doctors often avoid calling it purely autoimmune because gut bacteria and environment seem to drive the immune reaction too [12].

4. Can stress cause IBD?

Stress is not thought to cause IBD, but it can influence symptoms through the gut-brain axis [45].

5. What foods trigger IBD flares?

There is no universal list. Triggers differ between people, so a short, guided food and symptom diary works better than cutting out whole food groups [26].

6. Can you exercise with IBD?

Usually yes, and regular activity appears helpful during remission. Adjust intensity during flares and talk to your care team [48].

7. Can IBD cause weight loss and anaemia?

Yes. Poor absorption, reduced appetite, blood loss and inflammation can all contribute, which is why nutrient testing matters [37] [38].

This article is educational and does not replace medical care. If you have blood in your stool, persistent diarrhoea, unexplained weight loss or severe pain, see a doctor promptly.

References

1. Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn’s disease. Lancet, 2017.

2. Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet, 2017.

3. Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet, 2012.

4. Ng SC et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet, 2017.

5. Molodecky NA et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology, 2012.

6. Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol, 2015.

7. Kedia S, Ahuja V. Epidemiology of inflammatory bowel disease in India: the great shift east. Inflamm Intest Dis, 2017.

8. Pivot to Asia: inflammatory bowel disease burden. Intest Res, 2017.

9. Trends of inflammatory bowel disease from the Global Burden of Disease Study (1990-2019). Indian J Gastroenterol, 2024.

10. Snell A et al. Inflammatory bowel disease in India: challenges and opportunities. Frontline Gastroenterol, 2021.

11. Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol, 2015.

12. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol, 2010.

13. Frank DN et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. PNAS, 2007.

14. Mahid SS et al. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc, 2006.

15. Ungaro R et al. Antibiotics associated with increased risk of new-onset Crohn’s disease but not ulcerative colitis: a meta-analysis. Am J Gastroenterol, 2014.

16. Ananthakrishnan AN et al. Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study. Ann Intern Med, 2012.

17. van Rheenen PF et al. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ, 2010.

18. Menees SB et al. A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS. Am J Gastroenterol, 2015.

19. Halpin SJ, Ford AC. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol, 2012.

20. Limsrivilai J et al. Meta-analytic Bayesian model for differentiating intestinal tuberculosis from Crohn’s disease. Am J Gastroenterol, 2017.

21. Maaser C et al. ECCO-ESGAR guideline for diagnostic assessment in IBD. J Crohns Colitis, 2019.

22. Torres J et al. ECCO guidelines on therapeutics in Crohn’s disease: medical treatment. J Crohns Colitis, 2020.

23. Raine T et al. ECCO guidelines on therapeutics in ulcerative colitis: medical treatment. J Crohns Colitis, 2022.

24. Turner D et al. STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease initiative. Gastroenterology, 2021.

25. Lutgens MW et al. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis, 2013.

26. Lewis JD, Abreu MT. Diet as a trigger or therapy for inflammatory bowel diseases. Gastroenterology, 2017.

27. Levine A et al. Dietary guidance from the International Organization for the Study of Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol, 2020.

28. Narula N et al. Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study. BMJ, 2021.

29. Chassaing B et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature, 2015.

30. Ananthakrishnan AN et al. A prospective study of long-term intake of dietary fiber and risk of Crohn’s disease and ulcerative colitis. Gastroenterology, 2013.

31. Khalili H et al. Adherence to a Mediterranean diet is associated with a lower risk of later-onset Crohn’s disease. Gut, 2020.

32. Levine A et al. Crohn’s disease exclusion diet plus partial enteral nutrition induces sustained remission in a randomized controlled trial. Gastroenterology, 2019.

33. Narula N et al. Enteral nutritional therapy for induction of remission in Crohn’s disease. Cochrane Database Syst Rev, 2018.

34. Lewis JD et al. A randomized trial comparing the Specific Carbohydrate Diet to a Mediterranean diet in adults with Crohn’s disease. Gastroenterology, 2021.

35. Olendzki BC et al. An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report. Nutr J, 2014.

36. Cox SR et al. Effects of low FODMAP diet on symptoms, fecal microbiome, and markers of inflammation in patients with quiescent inflammatory bowel disease in a randomized trial. Gastroenterology, 2020.

37. Bischoff SC et al. ESPEN practical guideline: clinical nutrition in inflammatory bowel disease. Clin Nutr, 2020.

38. Kaitha S et al. Iron deficiency anemia in inflammatory bowel disease. World J Gastrointest Pathophysiol, 2015.

39. Dignass AU et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis, 2015.

40. Battat R et al. Vitamin B12 deficiency in inflammatory bowel disease: prevalence, risk factors, evaluation, and management. Inflamm Bowel Dis, 2014.

41. Parada Venegas D et al. Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol, 2019.

42. Sood A et al. The probiotic preparation VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin Gastroenterol Hepatol, 2009.

43. Paramsothy S et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet, 2017.

44. Hanai H et al. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol, 2006.

45. Gracie DJ, Hamlin PJ, Ford AC. The influence of the brain-gut axis in inflammatory bowel disease and possible implications for treatment. Lancet Gastroenterol Hepatol, 2019.

46. Gracie DJ et al. Effect of psychological therapy on disease activity, psychological distress, and quality of life in patients with inflammatory bowel disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol, 2017.

47. Khalili H et al. Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses’ Health Study cohorts. BMJ, 2013.

48. Jones PD et al. Exercise decreases risk of future active disease in patients with inflammatory bowel disease in remission. Inflamm Bowel Dis, 2015.

49. van Rheenen PF et al. The medical management of paediatric Crohn’s disease: an ECCO-ESPGHAN guideline update. J Crohns Colitis, 2021.

50. Turner D et al. Management of paediatric ulcerative colitis, part 1: ambulatory care. An evidence-based guideline from ECCO and ESPGHAN. J Pediatr Gastroenterol Nutr, 2018.